The Predictive Value of Pre-treatment Inflammatory Markers in Advanced Non-small-Cell Lung Cancer
Authors:
Open Access
- 1 August 2010
- journal article
- Published by MDPI AG in Current Oncology
- Vol. 17 (4) , 52-58
Abstract
Background: Accurate prediction of outcome in advanced non-small-cell lung cancer (NSCLC) remains challenging. Even within the same stage and treatment group, survival and response to treatment vary. We set out to determine the predictive value of inflammatory markers C-reactive protein (CRP) and white blood cells (WBCS) in patients with advanced NSCLC. Patients and Methods: Patients were assigned a prognostic index (PI): 0 for CRP 10 mg/L or less and WBCs 11×109/L or less, 1 if one of the two markers was elevated, and 2 if both markers were elevated. We then used chest computed tomography (CT) imaging to evaluate response after 2 cycles of chemotherapy treatment. Results: Of 134 patients, 46 had a PI of 0; 60, a PI of 1; and 28, a PI of 2. Disease progressed in 41 patients. Progression was significantly more frequent among patients with a PI of 2 (p = 0.008). Median survival was 20.0 months for the PI 0 group, 10.4 months for the PI 1 group, and 7.9 months for the PI 2 group (p < 0.001). The PI was the only significant prognostic factor for survival even after adjustment for performance status, smoking, and weight loss (hazard ratio: 1.57; 95% confidence interval: 1.2 to 2.14; p = 0.004). Conclusions: Inflammatory state correlates significantly with both chemotherapy response and survival in stage IV NSCLC. The PI may provide additional guidance for therapeutic decision-making.Keywords
This publication has 45 references indexed in Scilit:
- Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03European Journal of Cancer, 2009
- C-Reactive Protein Elicits White Blood Cell Activation in HumansThe American Journal of Medicine, 2009
- Neuroendocrine modulation of cancer progressionBrain, Behavior, and Immunity, 2009
- Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysisCancer Causes & Control, 2008
- Baseline elevated leukocyte count in peripheral blood is associated with poor survival in patients with advanced non-small cell lung cancer: a prognostic modelJournal of Cancer Research and Clinical Oncology, 2008
- Dendritic cells and innate defense against tumor cellsCytokine & Growth Factor Reviews, 2008
- C‐reactive protein is an informative predictor of renal cell carcinoma‐specific mortalityCancer, 2007
- Preoperative interleukin‐6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinomaCancer, 2007
- A prospective study on C-reactive protein as a prognostic factor for survival time of terminally ill cancer patientsSupportive Care in Cancer, 2007
- Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?European Journal of Cancer, 2006